Learn more

NORTHWEST BIOTHERAPEUTICS INC

Overview
  • Total Patents
    214
  • GoodIP Patent Rank
    42,039
  • Filing trend
    ⇧ 33.0%
About

NORTHWEST BIOTHERAPEUTICS INC has a total of 214 patent applications. It increased the IP activity by 33.0%. Its first patent ever was published in 1996. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are HEMOSOL INC, ACADEMISCH ZIEKENHUIS LEIDEN and SINAI SCHOOL MEDICINE.

Patent filings per year

Chart showing NORTHWEST BIOTHERAPEUTICS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Bosch Marnix L 113
#2 Boynton Alton L 79
#3 Lodge Patricia A 27
#4 Tjoa Benjamin A 22
#5 Murphy Gerald P 21
#6 Harris Paul C 15
#7 Sehgal Anil 14
#8 Monahan Steven J 13
#9 Lodge Patricia Anne 13
#10 Turner Allen 13

Latest patents

Publication Filing date Title
WO2021071977A1 In vitro methods and compositions for enhancing the activation of dendritic cells and t cells, and for inducing a th-1 immune response
AU2016228284A1 Administration of dendritic cells partially matured in vitro for the treatment of tumors
WO2017048875A1 Methods relating to activated dendritic cell compositions and immunotherapeutic treatments for subjects with advanced cancers
MX2018000056A Optimally activated dendritic cells that induce an improved or increased anti-tumor immune response.
AU2013234394A1 Administration of dendritic cells partially matured in vitro for the treatment of tumors
AU2013206016A1 Compositions and methods for inducing the activation of immature monocytic dendritic cells
AU2013201707A1 Compositions and methods for priming monocytic dendritic cells and T cells for Th-1 response
AU2011218747A1 Tangential flow filtration devices and methods for stem cell enrichment
AU2006321794A1 Compositions and methods for inducing the activation of immature monocytic dendritic cells
US2005189297A1 Tangential flow filtration devices and methods for stem cell enrichment
BRPI0407900A generation of dendritic cells from gm-csf monocytic dentitic precursor cells in the absence of additional cytokines
WO2004072262A2 Cultured cd14+ antigen presenting cells
US2004197903A1 Method for induction of proliferation of natural killer cells by dendritic cells cultured with GM-CSF and IL-15
CA2509058A1 Administration of dendritic cells partially matured in vitro for the treatment of tumors
NZ537188A Tangential flow filtration devices and methods for leukocyte enrichment
US2006234309A1 Quality assays for antigen presenting cells
IL155793D0 Monoclonal antibodies having an antigen binding region specific for the extracellular domain of prostrate specific membrane antigen (psma)
IL160720D0 Composition and methods for priming monocytic dendritic cells and t cells for th-1 response
AU2002326463A1 Methods and apparatus for enrichment and culture of monocytic dendritic cell precursors
AU2002252160A1 Connexin enhances chemotherapy-induced apoptosis in human cancer cells inhibiting tumor cell proliferation